Literature DB >> 22254217

Recent concepts for the roles of progenitor/stem cell niche in heart repair.

Yuliang Feng, Xi-Yong Yu, Yigang Wang.   

Abstract

Progenitor/stem cell (PSC) has shown great promise for generation in failing heart. Advances in PSC biology have greatly enhanced our understanding of how PSC self-renewal, migration, maintenance of stemness, and cell-fate commitment depend on the balance of complex signals in their microenvironment. Endogenous PSC exists within structural and functional units known as PSC niches, which play important roles in directing PSC behavior. Recent years have witnessed great progress in our understanding of the PSC niche in cardiovascular biology. PSC based therapy could lead to successful cardiac regeneration or repair. Realizing the potential of therapeutic strategies is based on 1) differentiation of the PSC into all of the cellular constituents of the heart; 2) release of paracrine/ autocrine factors from the PSC; 3) fusion of the PSC with the existing constituents of the heart; and 4) stimulation of endogenous repair (regeneration of PSC niches). Importantly, cardiac PSC niches contain supporting cells and these cell-cell interactions have crucial regulatory roles in PSC based therapy. These findings have important implications for heart development, bioengineering, and furthermore elucidate a broader dimension of PSC control within the niche toward cardiomyocyte phenotype.

Entities:  

Keywords:  Progenitor/stem cell; SDF-1α/CXCR4 axis; growth factors; myocardial infarction; progenitor/stem cell niches

Year:  2011        PMID: 22254217      PMCID: PMC3257154     

Source DB:  PubMed          Journal:  Am J Cardiovasc Dis        ISSN: 2160-200X


  64 in total

1.  Hypoxia enhances the generation of induced pluripotent stem cells.

Authors:  Yoshinori Yoshida; Kazutoshi Takahashi; Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Cell Stem Cell       Date:  2009-08-27       Impact factor: 24.633

2.  FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction.

Authors:  Felix B Engel; Patrick C H Hsieh; Richard T Lee; Mark T Keating
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-10       Impact factor: 11.205

3.  Stem cell differentiation requires a paracrine pathway in the heart.

Authors:  Atta Behfar; Leonid V Zingman; Denice M Hodgson; Jean-Michel Rauzier; Garvan C Kane; Andre Terzic; Michel Pucéat
Journal:  FASEB J       Date:  2002-10       Impact factor: 5.191

4.  Genetically manipulated progenitor cell sheet with diprotin A improves myocardial function and repair of infarcted hearts.

Authors:  Dongsheng Zhang; Wei Huang; Bo Dai; Tiemin Zhao; Atif Ashraf; Ronald W Millard; Muhammad Ashraf; Yigang Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-27       Impact factor: 4.733

5.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

Review 6.  Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells.

Authors:  Tsvee Lapidot; Isabelle Petit
Journal:  Exp Hematol       Date:  2002-09       Impact factor: 3.084

7.  Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction.

Authors:  Yigang Wang; Dongsheng Zhang; Muhammad Ashraf; Tiemin Zhao; Wei Huang; Atif Ashraf; Ambikaipakan Balasubramaniam
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-06       Impact factor: 4.733

8.  AMD3100 mobilizes endothelial progenitor cells in mice, but inhibits its biological functions by blocking an autocrine/paracrine regulatory loop of stromal cell derived factor-1 in vitro.

Authors:  Yangguang Yin; Lan Huang; Xiaohui Zhao; Yuqiang Fang; Shiyong Yu; Jinghong Zhao; Bing Cui
Journal:  J Cardiovasc Pharmacol       Date:  2007-07       Impact factor: 3.105

9.  G-CSF in patients suffering from late revascularised ST elevation myocardial infarction: final 1-year-results of the G-CSF-STEMI Trial.

Authors:  Markus G Engelmann; Hans D Theiss; Christine Theiss; Volkmar Henschel; Armin Huber; Bernd J Wintersperger; Stefan O Schoenberg; Gerhard Steinbeck; Wolfgang-M Franz
Journal:  Int J Cardiol       Date:  2009-05-27       Impact factor: 4.164

Review 10.  Cardiac cell repair therapy: a clinical perspective.

Authors:  Bernard J Gersh; Robert D Simari; Atta Behfar; Carmen M Terzic; Andre Terzic
Journal:  Mayo Clin Proc       Date:  2009-10       Impact factor: 7.616

View more
  4 in total

1.  Cardiac stem cell niche, MMP9, and culture and differentiation of embryonic stem cells.

Authors:  Paras Kumar Mishra; Nicholas John Kuypers; Shree Ram Singh; Noel Diaz Leiberh; Vishalakshi Chavali; Suresh C Tyagi
Journal:  Methods Mol Biol       Date:  2013

2.  Design and formulation of functional pluripotent stem cell-derived cardiac microtissues.

Authors:  Nimalan Thavandiran; Nicole Dubois; Alexander Mikryukov; Stéphane Massé; Bogdan Beca; Craig A Simmons; Vikram S Deshpande; J Patrick McGarry; Christopher S Chen; Kumaraswamy Nanthakumar; Gordon M Keller; Milica Radisic; Peter W Zandstra
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-19       Impact factor: 11.205

3.  Reduction of Na/K-ATPase affects cardiac remodeling and increases c-kit cell abundance in partial nephrectomized mice.

Authors:  Christopher A Drummond; Moustafa Sayed; Kaleigh L Evans; Huilin Shi; Xiaoliang Wang; Steven T Haller; Jiang Liu; Christopher J Cooper; Zijian Xie; Joseph I Shapiro; Jiang Tian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-04-18       Impact factor: 4.733

4.  Hypoxia-stressed cardiomyocytes promote early cardiac differentiation of cardiac stem cells through HIF-1α/Jagged1/Notch1 signaling.

Authors:  Keke Wang; Ranran Ding; Yanping Ha; Yanan Jia; Xiaomin Liao; Sisi Wang; Rujia Li; Zhihua Shen; Hui Xiong; Junli Guo; Wei Jie
Journal:  Acta Pharm Sin B       Date:  2018-06-12       Impact factor: 11.413

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.